Skip to content

Clinical Study on Acupuncture Treatment of Retinitis Pigmentosa

Clinical Study on Acupuncture Treatment of Retinitis Pigmentosa

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000004174
Enrollment
Unknown
Registered
2020-12-17
Start date
2020-12-30
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinitis Pigmentosa

Interventions

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of primary retinitis pigmentosa; 2. Age 7-80 years old, the course of disease is not limited to men and women; 3. The process of obtaining the informed consent is in line with the requirements of clinical trial management standards.

Exclusion criteria

Exclusion criteria: 1. The BCVA is less than 0.1; 2. Having other ophthalmic diseases such as amblyopia, diabetic retinopathy, glaucoma, severe cataract and other eye diseases that affect vision or cause blindness; 3. Patients with severe primary diseases such as cardiovascular and cerebrovascular diseases, liver and kidney diseases and hematopoietic systems; 4. Patients who use other relevant drugs or treat primary retinitis pigmentosa within 2 weeks; 5. Poor compliance, or participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
BCVA;View of MS, MD;

Secondary

MeasureTime frame
ERG;SFCT;SQL-VI;CMT;TCM syndrome complex integral;

Countries

China

Contacts

Public ContactHuang Hui

Hospital of Chengdu University of Traditional Chinese Medicine

397439643@qq.com+86 18782917219

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026